<DOC>
	<DOCNO>NCT00193076</DOCNO>
	<brief_summary>Pre-clinical data suggest combination therapy gemcitabine carboplatin synergistic , drug may synergistic trastuzumab . Additionally , recent clinical data suggest combination gemcitabine platinum active regimen metastatic breast cancer . This study test combination gemcitabine carboplatin patient metastatic breast cancer . Patients Her2/neu overexpression stratify receive trastuzumab addition gemcitabine carboplatin .</brief_summary>
	<brief_title>Combination Gemcitabine , Carboplatin With Without Trastuzumab Patients With Metastatic Breast Cancer</brief_title>
	<detailed_description>Upon determination eligibility , patient receive follow treatment : Gemcitabine + Carboplatin</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<mesh_term>Trastuzumab</mesh_term>
	<criteria>To include study , must meet following criterion : Locally advance metastatic breast cancer Measurable disease per RECIST criterion No prior chemotherapy metastatic breast set Prior chemotherapy and/or hormonal therapy early stage breast cancer Adjuvant Herceptin allow Prior radiation therapy either metastatic early stage set Patients may receive number hormonal therapy Age &gt; 18 year Only woman eligible study Able perform activity daily live minimal assistance Normal organ bone marrow function Patients receive Trastuzumab must normal heart function Sign write informed consent document You participate study follow apply : Received prior chemotherapy metastatic breast cancer Known leptomeningeal carcinomatosis Uncontrolled brain metastasis Uncontrolled intercurrent illness Pregnant lactate History nonbreast cancer malignancy Received prior chemotherapy early stage breast cancer within 6 month Please note : There additional inclusion/exclusion criterion . The study center determine meet criterion . If qualify trial , study personnel explain reason . If qualify , study personnel explain trial detail answer question may .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>